Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
Үндсэн зохиолчид: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
1998
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Monoclonal-antibody therapy in systemic vasculitis.
-н: Mathieson, P, зэрэг
Хэвлэсэн: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
-н: Mathieson, P, зэрэг
Хэвлэсэн: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
-н: Lockwood, C, зэрэг
Хэвлэсэн: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
-н: Lockwood, C, зэрэг
Хэвлэсэн: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
-н: Isaacs, J, зэрэг
Хэвлэсэн: (1993)